Spinal sigma-1 receptor activation increases the production of D-serine in astrocytes which contributes to the development of mechanical allodynia in a mouse model of neuropathic pain

Pharmacol Res. 2015 Oct:100:353-64. doi: 10.1016/j.phrs.2015.08.019. Epub 2015 Aug 24.

Abstract

We have previously demonstrated that activation of the spinal sigma-1 receptor (Sig-1R) plays an important role in the development of mechanical allodynia (MA) via secondary activation of the N-methyl-d-aspartate (NMDA) receptor. Sig-1Rs have been shown to localize to astrocytes, and blockade of Sig-1Rs inhibits the pathologic activation of astrocytes in neuropathic mice. However, the mechanism by which Sig-1R activation in astrocytes modulates NMDA receptors in neurons is currently unknown. d-serine, synthesized from l-serine by serine racemase (Srr) in astrocytes, is an endogenous co-agonist for the NMDA receptor glycine site and can control NMDA receptor activity. Here, we investigated the role of d-serine in the development of MA induced by spinal Sig-1R activation in chronic constriction injury (CCI) mice. The production of d-serine and Srr expression were both significantly increased in the spinal cord dorsal horn post-CCI surgery. Srr and d-serine were only localized to astrocytes in the superficial dorsal horn, while d-serine was also localized to neurons in the deep dorsal horn. Moreover, we found that Srr exists in astrocytes that express Sig-1Rs. The CCI-induced increase in the levels of d-serine and Srr was attenuated by sustained intrathecal treatment with the Sig-1R antagonist, BD-1047 during the induction phase of neuropathic pain. In behavioral experiments, degradation of endogenous d-serine with DAAO, or selective blockade of Srr by LSOS, effectively reduced the development of MA, but not thermal hyperalgesia in CCI mice. Finally, BD-1047 administration inhibited the development of MA and this inhibition was reversed by intrathecal treatment with exogenous d-serine. These findings demonstrate for the first time that the activation of Sig-1Rs increases the expression of Srr and d-serine in astrocytes. The increased production of d-serine induced by CCI ultimately affects dorsal horn neurons that are involved in the development of MA in neuropathic mice.

Keywords: Astrocyte; Mechanical allodynia; N-[2-(3,4-dichlorophenyl) ethyl]-N-methyl-2-(dimethylamino) ethylamine dihydro-bromide (PubChem CID: 188,914); Neuropathic pain; Sig-1R; d-serine; d-serine (PubChem CID: 71,077); l-serine O-sulfate potassium salt (PubChem CID: 5951).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Disease Models, Animal
  • Ethylenediamines / pharmacology
  • Hyperalgesia / metabolism*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Neuralgia / metabolism*
  • Posterior Horn Cells / metabolism
  • Racemases and Epimerases / metabolism
  • Receptors, sigma / metabolism*
  • Serine / metabolism*
  • Sigma-1 Receptor
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism

Substances

  • Ethylenediamines
  • Receptors, sigma
  • N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin
  • Serine
  • Racemases and Epimerases
  • serine racemase